Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

BACKGROUND: The identification of somatic mutations in the gene encoding the serine–threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to test oncogene-targeted therapy for this disease. METHODS: We conducted a multicenter, phase 1, dose-escalation trial of PLX4...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Flaherty, Keith T., Puzanov, Igor, Kim, Kevin B., Ribas, Antoni, McArthur, Grant A., Sosman, Jeffrey A., O'Dwyer, Peter J., Lee, Richard J., Grippo, Joseph F., Nolop, Keith, Chapman, Paul B.
格式: Artigo
語言:Inglês
出版: 2010
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3724529/
https://ncbi.nlm.nih.gov/pubmed/20818844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1002011
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍